title: The insulin glargine dilemma: an opportunity for the diabetes community?
authors.affiliation: Department of Medicine, University of Leipzig, Germany. michael.stumvoll@medizin.uni-leipzig.de
authors.forename: M
authors.initials: M
authors.lastname: Stumvoll
authors.forename: P P
authors.initials: PP
authors.lastname: Nawroth
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D004345:Drug Industry / Q000458:organization & administration* / Q000592:standards; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D033183:Interdisciplinary Communication; D011362:Professional Corporations / Q000458:organization & administration* / Q000592:standards; D015980:Public Health Practice
chemical_list: D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine
references.citation: Diabetologia. 2009 Sep;52(9):1745-54
references.pmid: 19588120
references.citation: Diabetologia. 2009 Sep;52(9):1971-3
references.pmid: 19609501
references.citation: Diabetes. 2000 Jun;49(6):999-1005
references.pmid: 10866053
references.citation: Diabetologia. 2009 Sep;52(9):1755-65
references.pmid: 19603149
references.citation: Diabetologia. 2009 Sep;52(9):1778-88
references.pmid: 19526210
references.citation: Diabetes Care. 2008 Jun;31(6):1105-11
references.pmid: 18316392
references.citation: Am Heart J. 2008 Jan;155(1):26-32, 32.e1-6
references.pmid: 18082485
references.citation: Diabetologia. 2009 Sep;52(9):1732-44
references.pmid: 19565214
references.citation: Diabetologia. 2009 Sep;52(9):1766-77
references.pmid: 19572116
references.citation: Diabetologia. 2009 Sep;52(9):1699-708
references.pmid: 19597799